Showing 946-960 of 1234
-
Exposure to isomers of per- and polyfluoroalkyl substances increases the risk of diabetes and impairs glucose-homeostasis in Chinese adults: Isomers of C8 health project
Science
23 Jun 2021 | Chemosphere
Chronic exposure to PFAS isomers was associated with impaired glucose levels and may increase the prevalence of type-2 diabetes in Chinese adults.
-
Serum vaccine antibody concentrations in adults exposed to per- and polyfluoroalkyl substances: A birth cohort in the Faroe Islands
Science
23 Jun 2021 | J Immunotoxicol
PFOA was associated with abnormal levels of antibodies in vaccinated adults.
-
Distribution Characteristics of Per- and Polyuoroalkyl Substances (PFASs) in Human Urines of Acrylic Fiber Plant and Chemical Plant
Science
22 Jun 2021 | Environ. Sci. Pollut. Res.
Short-chain PFAS (PFBA and PFBS) were becoming dominant for human exposure, especially occupational workers.
-
PFAS In Cosmetics: Financial and Insurance Companies On Notice
News
21 Jun 2021 | National Law Review
Cosmetics manufacturers and suppliers must take action now, if they have not already, to determine the scope of potential PFAS liability issues, spanning the gamut from environmental pollution to products liability / personal injury issues.
-
Trends in environmental chemical concentrations in the Canadian population: Biomonitoring data from the Canadian Health Measures Survey 2007-2017
Science
16 Jun 2021 | Environ Int
Concentrations of PFOA and PFOS decreased over a ten-year period in the Canadian population.
-
Differential susceptibility of rat primary neurons and neural stem cells to PFOS and PFOA toxicity
Science
16 Jun 2021 | Toxicol Lett
The PFAS-induced alterations in neurons observed in rodents may also impact development and brain disease.
-
Toxic, long-lasting contaminants detected in people living in northern Canada
News
13 Jun 2021 | The Conversation
Levels of PFNA were twice as high among northerners than observed in the general Canadian population.
-
Mich. lawsuit v. 3M, Wolverine re PFAS pollution proceeds
News
9 Jun 2021 | Reuters
The residents say the companies created a private and public nuisance by knowingly polluting their environment with PFAS.
-
Air monitoring with passive samplers for perfluoroalkane substances in developing countries (2017-2019)
Science
9 Jun 2021 | Chemosphere
41 developing countries were sampled, with Zambia showing exceptionally high levels of PFAS.
-
Perfluoroalkyl Substances in Plasma of Smallmouth Bass from the Chesapeake Bay Watershed
Science
9 Jun 2021 | Int J Environ Res Public Health
PFUnA and PFDoA concentrations were higher in males than females in a New England population with potentially both agricultural and developed land use associated with exposure.
-
Exploring associations between prenatal exposure to multiple endocrine disruptors and birth weight with exposure continuum mapping
Science
9 Jun 2021 | Environ Res
Increased levels of PFAS were associated with heavier babies.
-
Associations of perfluoroalkyl and polyfluoroalkyl substances (PFAS) and PFAS mixtures with adipokines in midlife women
Science
9 Jun 2021 | Int J Hyg Environ Health
Some PFAS may alter circulating levels of leptin, affecting the ‘hunger’ sensation.
-
Determination of perfluorooctane sulphonate and perfluorooctanoic acid in seafood and water from Map Ta Phut Industrial Estate area, Thailand
Science
9 Jun 2021 | Food Addit Contam Part A Chem Anal Control Expo Risk Assess
PFOS levels exceeded the total tolerable weekly intake value for PFAS mixtures in a Thai population.
-
Perfluorotridecanoic Acid Inhibits Leydig Cell Maturation in Male Rats in Late Puberty via Changing Testicular Lipid Component
Science
9 Jun 2021 | Chem Res Toxicol
PFTrDA delays the maturation of testicle cells in late puberty mainly by altering the free fatty acid profile.
-
Early-life associations between per- and polyfluoroalkyl substances and serum lipids in a longitudinal birth cohort
Science
8 Jun 2021 | Environ Res
Childhood PFAS exposures may be associated with elevated serum lipid concentrations which can be a predictor of later development of hyperlipidemia and cardiovascular disease.